Brief: Targovax Announces Clinical Collaboration With Agenus For Upcoming Oncos-102 Phase 2 Melanoma Trial

Circio Holding ASA

11/05/2022 14:36

May 11 (Reuters) - Targovax ASA  TRVX.OL :
    * TARGOVAX ANNOUNCES CLINICAL COLLABORATION WITH AGENUS FOR
UPCOMING ONCOS-102 PHASE 2 MELANOMA TRIAL
    * UNDER AGREEMENT, TARGOVAX WILL BE SPONSOR AND RESPONSIBLE
FOR
OPERATIONAL EXECUTION OF COMBINATION TRIAL, AND AGENUS WILL
PROVIDE DRUG SUPPLY AND SCIENTIFIC SUPPORT

Source text for Eikon:  ID:nWkr7zDpdD 
Further company coverage:  TRVX.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))